ANAPTYSBIO, INC (ANAB) Files Proxy Statement Ahead of Shareholder Meeting
Filing Details ANAPTYSBIO, INC (NASDAQ:ANAB) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on June 29, 2026. The Healthcare company's…
Read more
